Monopar Therapeutics Inc. · NASDAQ:MNPR
Monopar Therapeutics Inc. shareholders
As of Sep 30, 2026, 103 institutions reported holding Monopar Therapeutics Inc., 91.7% of its shares. Largest: Janus Henderson, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Monopar Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Janus Henderson | 1.12M | 16.5% | first report | Nov 16, 2026 |
| Ra Capital Management, L.P. | 667K | 9.8% | no change | Nov 16, 2026 |
| BlackRock | 349K | 5.2% | +425 | Nov 13, 2026 |
| Saturn V Capital Management LP | 312K | 4.6% | +374 | Nov 16, 2026 |
| Vanguard | 294K | 4.3% | +5,716 | Nov 13, 2026 |
| Siren, L.L.C. | 270K | 4.0% | no change | Nov 12, 2026 |
| State Street | 230K | 3.4% | +137K | Nov 12, 2026 |
| Polar Capital Holdings Plc | 214K | 3.2% | −658 | Nov 16, 2026 |
| Adage Capital Partners Gp, L.L.C. | 209K | 3.1% | no change | Nov 16, 2026 |
| TCG Crossover Management, LLC | 202K | 3.0% | −1,085 | Nov 16, 2026 |